Pharmacology of PEG-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Pinheiro
Joao Paulo Vieira
JP
Lanvers
Claudia
C
Würthwein
Gudrun
G
Boos
Joachim
J
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001215:Asparaginase / Q000008:administration & dosage* / Q000737:chemistry; D001216:Asparagine / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli; D006801:Humans; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000737:chemistry; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D001216:Asparagine; D001215:Asparaginase